N45
6'-[(6-aminopyrimidin-4-yl)amino]-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione
Find entries where: N45
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 6'-[(6-aminopyrimidin-4-yl)amino]-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione |
Identifiers | 6-[(6-azanylpyrimidin-4-yl)amino]-8-methyl-spiro[2~{H}-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-1,5-dione |
Formula | C17 H20 N6 O2 |
Molecular Weight | 340.38 |
Type | NON-POLYMER |
Isomeric SMILES | CC1=C2C(=O)NC3(N2C(=O)C(=C1)Nc4cc(ncn4)N)CCCCC3 |
InChI | InChI=1S/C17H20N6O2/c1-10-7-11(21-13-8-12(18)19-9-20-13)16(25)23-14(10)15(24)22-17(23)5-3-2-4-6-17/h7-9H,2-6H2,1H3,(H,22,24)(H3,18,19,20,21) |
InChIKey | HKTBYUWLRDZAJK-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 45 |
Chiral Atom Count | 0 |
Bond Count | 48 |
Aromatic Bond Count | 6 |
Drug Info: DrugBank
DrugBank ID | DB15219 |
---|---|
Name | Tomivosertib |
Groups | investigational |
Description | Tomivosertib is under investigation in clinical trial NCT03318562 (A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC). |
Synonyms |
|
CAS number | 1849590-01-7 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 118598754 |
ChEMBL | CHEMBL4073443 |
Pharos | CHEMBL4073443 |